Prevalence of Cheyne-Stokes respiration in modern treated congestive heart failure.
BACKGROUND
The prevalence of sleep breathing disorders in patients with congestive heart failure is relevantly high. According to historical studies Cheyne-Stokes respiration is an oscillatory ventilation during sleep in up to 40% of patients with congestive heart failure. During the last decade the medical treatment of congestive heart failure has been improved. The aim of this investigation was to analyze the prevalence of Cheyne-Stokes respiration in patients with congestive heart failure and modern medical treatment.


CONCLUSIONS
In 50 patients with severe congestive heart failure receiving modern medical treatment a full night polysomnography was performed. All patients had ss-blockers and angiotensin-converting-enzyme inhibitors or angiotensin-II-antagonists as standard treatment. The mean age was 63 +/- 12 years and the mean left ventricular ejection fraction was 26 +/- 6%. Respiratory polygraphy revealed Cheyne-Stokes respiration with a respiratory disturbance index of > or =5/h sleep in 32 (64%) of the seven female and 43 male patients. The prevalence of Cheyne-Stokes respiration defined by using the threshold of an apnea index of > or =10/h was 30%.


CONCLUSIONS
Thus, no significant change of Cheyne-Stokes prevalence could be found in our modern treated severe congestive heart failure collective.
Hagenah
Gerrit
G
Department of Internal Medicine, Georg-August-Universität, Göttingen, Germany. hagenah@med.uni-goettingen.de
Beil
Dennis
D
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001827:Body Height; D015992:Body Mass Index; D002639:Cheyne-Stokes Respiration / Q000175:diagnosis* / Q000453:epidemiology*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017286:Polysomnography; D015995:Prevalence; D012720:Severity of Illness Index; D012891:Sleep Apnea Syndromes / Q000175:diagnosis / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors
Am J Respir Crit Care Med. 1996 Jan;153(1):272-6
8542128
Eur J Appl Physiol. 2005 Aug;94(5-6):569-75
15940534
N Engl J Med. 1991 Aug 1;325(5):293-302
2057034
Lancet. 1994 May 7;343(8906):1115-22
7910229
Circulation. 1999 Mar 23;99(11):1435-40
10086966
Thorax. 2002 Jun;57(6):547-54
12037232
N Engl J Med. 2001 Dec 6;345(23):1667-75
11759645
Br Heart J. 1995 Mar;73(3):237-41
7727183
Chest. 1994 Dec;106(6):1689-94
7988185
Chest. 2007 Jan;131(1):130-5
17218566
Eur Respir J. 2007 Jun;29(6):1201-5
17360729
Am J Cardiol. 1996 Dec 1;78(11):1260-4
8960586
South Med J. 1985 Jan;78(1):11-5
3966165
Circulation. 1998 Jun 2;97(21):2154-9
9626176
Lancet. 2000 May 6;355(9215):1582-7
10821361
Lancet. 1999 Jun 12;353(9169):2001-7
10376614
Am J Respir Crit Care Med. 1999 Oct;160(4):1101-6
10508793
Eur Respir J. 2004 Dec;24(6):987-93
15572543
Eur Heart J. 2006 Aug;27(15):1773-7
16820365
Lancet. 1999 Jan 2;353(9146):9-13
10023943
Respir Med. 2007 Apr;101(4):850-3
17223328